Published in Blood Weekly, July 12th, 2007
Other major new investors include Quest for Growth and MedSciences Capital. All of the major existing investors also contributed to this round, including founding investor Life Sciences Partners, Esprit Capital Partners LLP and N.V. NOM (Investment and Development Agency for the Northern Netherlands).
The Kiadis Pharma product pipeline is focused on providing novel treatments for significant unmet medical needs...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.